Cooperative growth-inhibitory effects between CDK4/CDK6 inhibitors and midostaurin were also confirmed in primary neoplastic cells, as exemplified for one patient with midostaurin-resistant MCL (Figure 5G). This evidence concerns the gene CDK6 and mantle cell lymphoma.